We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Helping public health practitioners conducting evaluations – developing a logic model to represent how your intervention works.
How to comply with the exemption from the Veterinary Medicines Regulations that allow certain animal medicines to be sold without a marketing authorisation.
How to apply for marketing authorisation via this new procedure.
This webinar looks at the information an organisation makes available to clients, or potential clients, and how the consumer's expectations can be met.
Guidance for the veterinary pharmaceutical industry on the production of mock-ups for assessment.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Register as a manufacturer, importer or distributor of active substances for use in veterinary medicines.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
A series of indicators to inform safer prescribing practice to help pharmacists, clinicians and patients review prescribed medication and prevent harm.
The What Works Network uses evidence to improve the design and delivery of public services.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Submission dates and how the submissions using the EC decision reliance procedure work.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).